Column Group IV GP, LP insider trades: Eikon Therapeutics (EIKN) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Column Group IV GP, LP reports to the SEC
Open-market buys and sales
28 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | EIKN | ↑ Buy | 89,200 | $11.56 | $1.0M | Indirect | Sep 8, 2026 (5d) |
| Feb 6, 2026 | EIKN | ↑ Buy | 1,437,323 | $18.00 | $25.9M | By The Column Group IV, LP | Feb 9, 2026 (3d) |
| Feb 6, 2026 | EIKN | ↑ Buy | 630,881 | $18.00 | $11.4M | By The Column Group Opportunity III, LP | Feb 9, 2026 (3d) |
| Feb 6, 2026 | EIKN | ↑ Buy | 49,556 | $18.00 | $892K | By The Column Group IV-A, LP | Feb 9, 2026 (3d) |
| Nov 16, 2023 | NGM | ↑ Buy | 22,631 | $0.69 | $16K | Indirect | Nov 17, 2023 (1d) |
| Jan 31, 2023 | NGM | ↑ Buy | 184,272 | $5.00 | $921K | Indirect | Feb 1, 2023 (1d) |
| Jan 23, 2023 | NGM | ↑ Buy | 9,900 | $5.00 | $49K | Indirect | Jan 25, 2023 (2d) |
| Jan 20, 2023 | NGM | ↑ Buy | 38,139 | $5.00 | $191K | Indirect | Jan 23, 2023 (3d) |
| Jan 12, 2023 | NGM | ↑ Buy | 5,378 | $4.95 | $27K | Indirect | Jan 17, 2023 (5d) |
| Jan 11, 2023 | NGM | ↑ Buy | 309,070 | $4.79 | $1.5M | Indirect | Jan 12, 2023 (1d) |
| Dec 12, 2022 | NGM | ↑ Buy | 300 | $4.98 | $1K | Indirect | Dec 14, 2022 (2d) |
| Nov 22, 2022 | NGM | ↑ Buy | 40,327 | $5.00 | $202K | Indirect | Nov 23, 2022 (1d) |
| Nov 4, 2022 | NGM | ↑ Buy | 139,148 | $4.92 | $684K | Indirect | Nov 7, 2022 (3d) |
| Oct 27, 2022 | NGM | ↑ Buy | 76,877 | $4.86 | $374K | Indirect | Oct 31, 2022 (4d) |
| Oct 26, 2022 | NGM | ↑ Buy | 123,820 | $4.81 | $595K | Indirect | Oct 27, 2022 (1d) |
| Jun 9, 2022 | NGM | ↑ Buy | 984,161 | $13.50 | $13.3M | Indirect | Jun 13, 2022 (4d) |
| Jun 2, 2022 | NGM | ↑ Buy | 34,200 | $13.03 | $446K | Indirect | Jun 6, 2022 (4d) |
| Jun 1, 2022 | NGM | ↑ Buy | 153,806 | $13.46 | $2.1M | Indirect | Jun 2, 2022 (1d) |
| May 27, 2022 | NGM | ↑ Buy | 22,911 | $13.49 | $309K | Indirect | May 31, 2022 (4d) |
| May 25, 2022 | RAPT | ↑ Buy | 1,900 | $12.45 | $24K | Indirect | May 27, 2022 (2d) |
| May 25, 2022 | NGM | ↑ Buy | 61,120 | $13.42 | $820K | Indirect | May 26, 2022 (1d) |
| May 24, 2022 | RAPT | ↑ Buy | 26,550 | $12.19 | $324K | Indirect | May 25, 2022 (1d) |
| May 20, 2022 | NGM | ↑ Buy | 39,700 | $13.36 | $530K | Indirect | May 23, 2022 (3d) |
| May 18, 2022 | NGM | ↑ Buy | 151,699 | $13.33 | $2.0M | Indirect | May 19, 2022 (1d) |
| May 16, 2022 | NGM | ↑ Buy | 33,166 | $12.90 | $428K | Indirect | May 17, 2022 (1d) |
| May 12, 2022 | NGM | ↑ Buy | 166,350 | $11.43 | $1.9M | Indirect | May 13, 2022 (1d) |
| May 10, 2022 | RAPT | ↑ Buy | 1,250,000 | $10.67 | $13.3M | Indirect | May 12, 2022 (2d) |
| May 10, 2022 | NGM | ↑ Buy | 114,440 | $10.95 | $1.3M | Indirect | May 11, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EIKN insiders
Open-market trades in the last 12 months
About Column Group IV GP, LP's insider trades
Column Group IV GP, LP is an insider at Eikon Therapeutics (EIKN). Since May 10, 2022, it has reported 28 open-market purchases worth $80.4M and no sales on SEC Form 4. In the last 12 months: 4 buys ($39.2M).
Its filings also include other transactions (2 filings), conversions (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EIKN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.